Literature DB >> 16896307

Synaptic vulnerability in neurodegenerative disease.

Thomas M Wishart1, Simon H Parson, Thomas H Gillingwater.   

Abstract

Recent developments in our understanding of the pathophysiological mechanisms underlying degeneration in both the central and peripheral nervous systems have highlighted the critical role that synapses play in the instigation and progression of neuronal loss. In fact, several lines of evidence suggest that previous attempts to delay the onset and progression of clinical symptoms in a broad range of neurodegenerative diseases may have been unsuccessful as a result of a failure to protect synaptic compartments. As a result, the synapse needs to be viewed as an important target for the development of novel protective treatments aimed at preventing or slowing disease progression. We summarize important findings from human studies and animal models demonstrating common synaptic vulnerability across several neurodegenerative diseases. We also discuss recent developments in our understanding of degenerative mechanisms that are known to be localized to synapses and suggest potential ways to harness this understanding to develop synaptoprotective strategies for neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896307     DOI: 10.1097/01.jnen.0000228202.35163.c4

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  79 in total

1.  CSPα knockout causes neurodegeneration by impairing SNAP-25 function.

Authors:  Manu Sharma; Jacqueline Burré; Peter Bronk; Yingsha Zhang; Wei Xu; Thomas C Südhof
Journal:  EMBO J       Date:  2011-12-20       Impact factor: 11.598

2.  Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.

Authors:  Surendra K Ravula; Min S Wang; Maxine A McClain; Seneshaw A Asress; Bruno Frazier; Jonathan D Glass
Journal:  Neurosci Lett       Date:  2007-01-10       Impact factor: 3.046

3.  Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models.

Authors:  Charleen T Chu; Edward D Plowey; Ruben K Dagda; Robert W Hickey; Salvatore J Cherra; Robert S B Clark
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 4.  Axonal transport defects in neurodegenerative diseases.

Authors:  Gerardo A Morfini; Matthew Burns; Lester I Binder; Nicholas M Kanaan; Nichole LaPointe; Daryl A Bosco; Robert H Brown; Hannah Brown; Ashutosh Tiwari; Lawrence Hayward; Julia Edgar; Klaus-Armin Nave; James Garberrn; Yuka Atagi; Yuyu Song; Gustavo Pigino; Scott T Brady
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

5.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

6.  GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.

Authors:  Catarina A R V Gomes; Patrícia F Simões; Paula M Canas; César Quiroz; Ana M Sebastião; Sergi Ferré; Rodrigo A Cunha; Joaquim A Ribeiro
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

Review 7.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

8.  Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease.

Authors:  Svetlana Sarantseva; Svetlana Timoshenko; Olga Bolshakova; Eugenia Karaseva; Dmitry Rodin; Alexander L Schwarzman; Michael P Vitek
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

9.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

10.  Expression of the neuroprotective slow Wallerian degeneration (WldS) gene in non-neuronal tissues.

Authors:  Thomas M Wishart; David G Brownstein; Derek Thomson; Anca M Tabakova; Katherine M Boothe; Jack W Tsao; Thomas H Gillingwater
Journal:  BMC Neurosci       Date:  2009-12-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.